AVM Biotechnology, LLC, a clinical stage company advancing AVM0703 in the treatment of Non-Hodgkin’s Lymphoma…
dcorriganApril 6, 2022
Scientists have built a new space for collaboration — at the microscopic level. The Allen…
dcorriganApril 5, 2022
Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance (SCCA), Seattle Children’s and UW Medicine…
dcorriganApril 4, 2022
Zinc’s immune-boosting properties are well-established, but we’re still untangling how it works. In a new study published in late…
dcorriganApril 4, 2022
Leiomyosarcoma (LMS) and liposarcoma (LPS) frequently express PD-L1 but are generally resistant to PD-1/PD-L1 inhibition…
dcorriganApril 4, 2022
Arzeda announced that it has closed a $33 million investment, in a Series B round…
dcorriganApril 1, 2022
Philip Greenberg has been trying to stop cancer for decades. With Affini-T Therapeutics, the Fred Hutchinson…
dcorriganApril 1, 2022
UW Medicine genome scientists were among the leading contributors to the publication of the first…
dcorriganApril 1, 2022
The authors have previously showed that pericyte-like cells derived from the FoxD1-lineage contribute to myofibroblasts…
dcorriganMarch 31, 2022
